Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Makoto, Hijikata"'
Autor:
Grace Naswa Makokha, Huarui Bao, C. Nelson Hayes, Maidina Abuduwaili, Elijah Songok, Makoto Hijikata, Kazuaki Chayama
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 3, Pp 677-689 (2024)
Abstract Background Hepatitis C (HCV) is a virus that causes chronic liver disease, end-stage cirrhosis, and liver cancer, yet most infected individuals remain undiagnosed or untreated. Kenya is a country located in Sub-Saharan Africa (SSA) where the
Externí odkaz:
https://doaj.org/article/c50aff9df7f04f68b655711e1ec828f8
Autor:
Yuichi Akahori, Hiroki Kato, Takashi Fujita, Kohji Moriishi, Yasuhito Tanaka, Koichi Watashi, Michio Imamura, Kazuaki Chayama, Takaji Wakita, Makoto Hijikata
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Recent development of hepatitis B virus (HBV) culture systems has made it possible to analyze the almost all steps of the viral life cycle. However, the reproducibility of interaction between HBV and host cells seemed inaccurate in those sys
Externí odkaz:
https://doaj.org/article/24c87ff8e1ec41cd8e076d743a800587
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Takashi Nakahara, Masataka Tsuge, C. Nelson Hayes, Hiroshi Aikata, Kazuaki Chayama, Eisuke Murakami, Kazuki Ohya, Hiromi Abe-Chayama, Tomokazu Kawaoka, Takuro Uchida, Atsushi Ono, Yuji Ishida, Masami Yamauchi, HoJoong Song, Chise Tateno, Hatsue Fujino, Makoto Hijikata, Michio Imamura, Yuji Teraoka, Yohei Miyayama, Daiki Miki
Publikováno v:
Biochemical and Biophysical Research Communications. 559:78-83
Combination therapy with glecaprevir and pibrentasvir (PIB) has high efficacy for patients with hepatitis C virus (HCV) infection except among those who experienced NS5A-P32 deletion (del) mutation during prior DAA treatment failure. However, some pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04518774a3864ef0d19a586b5fa2769
https://doi.org/10.1016/j.bbrc.2021.04.062
https://doi.org/10.1016/j.bbrc.2021.04.062
Autor:
Yuichi Akahori, Makoto Hijikata
Publikováno v:
Uirusu. 70(2)
Recent development of hepatitis B virus (HBV) culture systems has proceeded the molecular virological studies of the life cycle of HBV including infection step. However, the reproduction of HBV life cycle under the more physiological condition may be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73baa0481d592bc0a76c610e9396d6c4
https://pubmed.ncbi.nlm.nih.gov/34544928
https://pubmed.ncbi.nlm.nih.gov/34544928
Autor:
C. Nelson Hayes, Takuro Uchida, Yohei Miyayama, Masataka Tsuge, Hiromi Abe-Chayama, Mitsutaka Osawa, Yuji Teraoka, Eisuke Murakami, Hatsue Fujino, Daiki Miki, Kazuaki Chayama, Yuji Ishida, Tomokazu Kawaoka, Grace Naswa Makokha, Makoto Hijikata, Michio Imamura, Takashi Nakahara, Hiroshi Aikata, Atsushi Ono, Akira Hiramatsu, Chise Tateno
Publikováno v:
Journal of General Virology. 100:1123-1131
Combination therapy with glecaprevir (GLE) and pibrentasvir (PIB) has high efficacy for pan-genotypic hepatitis C virus (HCV)-infected patients. However, the efficacy for patients who acquired potent NS5A inhibitor resistance-associated variants (RAV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2602fbd3d1db0ac65be315c2e6b77627
https://doi.org/10.1099/jgv.0.001268
https://doi.org/10.1099/jgv.0.001268
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89869 (2014)
Several viruses are known to infect human liver and cause the hepatitis, but the interferon (IFN) response, a first-line defense against viral infection, of virus-infected hepatocytes is not clearly defined yet. We investigated innate immune system a
Externí odkaz:
https://doaj.org/article/9e31fc45da3c4ea5aee66c0e17dc539d
Autor:
Takashi Fujita, Makoto Hijikata, Michio Imamura, Yuichi Akahori, Kazuaki Chayama, Kohji Moriishi, Hiroki Kato, Yasuhito Tanaka, Takaji Wakita, Koichi Watashi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Recent development of hepatitis B virus (HBV) culture systems has made it possible to analyze the almost all steps of the viral life cycle. However, the reproducibility of interaction between HBV and host cells seemed inaccurate in those systems beca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54ec910ab32243efa3760ee9421da5d
https://pubmed.ncbi.nlm.nih.gov/33303813
https://pubmed.ncbi.nlm.nih.gov/33303813
Autor:
Hiromi Abe-Chayama, Daiki Miki, Yohei Miyayama, Makoto Hijikata, Michio Imamura, HoJoong Song, Heini Lee, Kazuaki Chayama
Publikováno v:
Microbiology and immunologyREFERENCES. 64(4)
The replicon system, which mimics viral genome replication in culture cells, has been widely used to analyze the genome replication of the hepatitis C virus (HCV). However, most HCV genomes used in the system include adaptive mutations (AMs) that are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d2df20e03bbad387bcff45d0434d71
https://pubmed.ncbi.nlm.nih.gov/31854467
https://pubmed.ncbi.nlm.nih.gov/31854467
Autor:
Makoto Hijikata, Kazumi Yagasaki, Yasunori Nio, Fumihiro Kato, Shigeru Tajima, Isao Miyazaki, Tomoyuki Miura, Takayuki Hishiki, Tomohiko Takasaki, Rieko Suzuki, Masayuki Saijo, Chang-Kweng Lim
Publikováno v:
Antiviral research. 172
Dengue virus (DENV) is the causative agent of dengue fever (DF), dengue haemorrhagic fever (DHF), and dengue shock syndrome (DSS) and continues to be a public health problem in the tropical and subtropical areas. However, there is currently no antivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ffc1ca8e3956b43385127d4d70c74e7
https://pubmed.ncbi.nlm.nih.gov/31678478
https://pubmed.ncbi.nlm.nih.gov/31678478